Paradigm Biopharmaceuticals Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

ASX:PAR Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Shares	Max Price
15 Oct 24	BuyAU$50,909	Paul Rennie	Individual	245,300	AU$0.21
14 Oct 24	BuyAU$73,274	Matthew Fry	Individual	350,000	AU$0.21
24 Sep 24	SellAU$891,158	Allianz Asset Management GmbH	Company	3,935,875	AU$0.27
17 May 24	SellAU$135,591	Allianz Asset Management GmbH	Company	4,283,087	AU$1.42

Insider Trading Volume

Insider Buying: PAR insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of PAR?
Owner Type	Number of Shares	Ownership Percentage
Private Companies	17,001,501	4.87%
Individual Insiders	27,363,410	7.83%
Institutions	58,130,585	16.6%
General Public	246,931,527	70.7%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 23 shareholders own 29.33% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
4.97%	Allianz Asset Management GmbH	17,372,860	AU$6.5m	-18.5%	no data
4.34%	Collins St Asset Management Pty Ltd	15,148,692	AU$5.7m	596%	3.69%
3.26%	Kzee Pty Ltd	11,380,902	AU$4.3m	0%	no data
2.95%	RBC Global Asset Management Inc.	10,310,378	AU$3.9m	0%	no data
2.67%	Paul Rennie	9,345,848	AU$3.5m	0.52%	no data
2.07%	Netwealth Investments Ltd.	7,233,311	AU$2.7m	0.47%	0.02%
0.99%	Nancy Wilson-Ghosh	3,475,835	AU$1.3m	0%	no data
0.88%	Evan Clucas	3,064,598	AU$1.1m	91.1%	no data
0.88%	Leanne Weston	3,064,597	AU$1.1m	91.1%	no data
0.69%	39KP Pty Ltd	2,427,367	AU$910.3k	65.2%	no data
0.69%	Adam Huts	2,405,000	AU$901.9k	0%	no data
0.67%	Fiftyone Capital Pty Ltd	2,337,318	AU$876.5k	-41%	no data
0.64%	Pictet Asset Management Limited	2,249,331	AU$843.5k	0%	no data
0.59%	Anthony Van Der Steeg	2,051,787	AU$769.4k	0%	no data
0.46%	Juzcorp Pty Limited	1,607,958	AU$603.0k	0%	no data
0.45%	Pershing Securities Australia Pty. Ltd.	1,585,274	AU$594.5k	0%	no data
0.45%	Flinders Medical Centre Foundation	1,562,000	AU$585.8k	10%	100.0%
0.41%	Lingtye Yu	1,441,631	AU$540.6k	0%	no data
0.41%	Matthew Fry	1,419,830	AU$532.4k	32.7%	no data
0.31%	Donna Skerrett	1,094,284	AU$410.4k	0%	no data
0.26%	Pictet Asset Management (Singapore) Pte Ltd	906,940	AU$340.1k	0%	0.27%
0.23%	Australian Super Pty Ltd	804,511	AU$301.7k	0%	no data
0.059%	Dimensional Fund Advisors LP	205,244	AU$77.0k	0.09%	no data

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2024/12/21 08:46
End of Day Share Price	2024/12/20 00:00
Earnings	2024/06/30
Annual Earnings	2024/06/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Paradigm Biopharmaceuticals Limited is covered by 4 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
John Hester	Bell Potter
Soo Romanoff	Edison Investment Research
Arron Aatkar	Edison Investment Research